» Articles » PMID: 22907054

Peroxisome Proliferator-activated Receptor γ Coactivator1- Gene α Transfer Restores Mitochondrial Biomass and Improves Mitochondrial Calcium Handling in Post-necrotic Mdx Mouse Skeletal Muscle

Overview
Journal J Physiol
Specialty Physiology
Date 2012 Aug 22
PMID 22907054
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Alterations of mitochondrial function have been implicated in the pathogenesis of Duchenne muscular dystrophy. In the present study, mitochondrial respiratory function, reactive oxygen species (ROS) dynamics and susceptibility to Ca(2+)-induced permeability transition pore (PTP) opening were investigated in permeabilized skeletal muscle fibres of 6-week-old mdx mice, in order to characterize the magnitude and nature of mitochondrial dysfunction at an early post-necrotic stage of the disease. Short-term overexpression of the transcriptional co-activator PGC1α, achieved by in vivo plasmid transfection, was then performed to determine whether this intervention could prevent mitochondrial impairment and mitigate associated biochemical abnormalities. Compared with normal mice, mdx mice exhibited a lower mitochondrial biomass and oxidative capacity, greater ROS buffering capabilities, and an increased vulnerability to Ca(2+)-induced opening of the mitochondrial permeability transition pore complex. PGC1α gene transfer restored mitochondrial biomass, normalized the susceptibility to PTP opening and increased the capacity of mitochondria to buffer Ca(2+)(.) This was associated with reductions in the activity levels of the Ca(2+)-dependent protease calpain as well as caspases 3 and 9. Overall, these results suggest that overexpression of PGC1α in dystrophin-deficient muscles, after the onset of necrosis, has direct beneficial effects upon multiple aspects of mitochondrial function, which may in turn mitigate the activation of proteolytic and apoptotic signalling pathways associated with disease progression.

Citing Articles

Inhibition of Mitochondrial Fission Protein Drp1 Ameliorates Myopathy in the D2-mdx Model of Duchenne Muscular Dystrophy.

Rosen H, Berger N, Hodge S, Fujishiro A, Lourie J, Kapadia V bioRxiv. 2025; .

PMID: 39763900 PMC: 11703253. DOI: 10.1101/2024.12.26.628172.


Molecular pathways involved in the control of contractile and metabolic properties of skeletal muscle fibers as potential therapeutic targets for Duchenne muscular dystrophy.

Bonato A, Raparelli G, Caruso M Front Physiol. 2024; 15:1496870.

PMID: 39717824 PMC: 11663947. DOI: 10.3389/fphys.2024.1496870.


Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response.

Gandhi S, Sweeney H, Hart C, Han R, Perry C Cells. 2024; 13(14.

PMID: 39056750 PMC: 11274633. DOI: 10.3390/cells13141168.


PINK1 deficiency alters muscle stem cell fate decision and muscle regenerative capacity.

Cairns G, Thumiah-Mootoo M, Abbasi M, Gourlay M, Racine J, Larionov N Stem Cell Reports. 2024; 19(5):673-688.

PMID: 38579709 PMC: 11103785. DOI: 10.1016/j.stemcr.2024.03.004.


Myonectin protects against skeletal muscle dysfunction in male mice through activation of AMPK/PGC1α pathway.

Ozaki Y, Ohashi K, Otaka N, Kawanishi H, Takikawa T, Fang L Nat Commun. 2023; 14(1):4675.

PMID: 37542026 PMC: 10403505. DOI: 10.1038/s41467-023-40435-2.


References
1.
Fraysse B, Nagi S, Boher B, Ragot H, Laine J, Salmon A . Ca2+ overload and mitochondrial permeability transition pore activation in living delta-sarcoglycan-deficient cardiomyocytes. Am J Physiol Cell Physiol. 2010; 299(3):C706-13. DOI: 10.1152/ajpcell.00545.2009. View

2.
Reutenauer J, Dorchies O, Patthey-Vuadens O, Vuagniaux G, Ruegg U . Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Br J Pharmacol. 2008; 155(4):574-84. PMC: 2579666. DOI: 10.1038/bjp.2008.285. View

3.
Fournier-Bidoz S, Le Cam G, Chambon C, Millasseau P, Leger J, Dechesne C . Down-regulation of mitochondrial mRNAs in the mdx mouse model for Duchenne muscular dystrophy. FEBS Lett. 1995; 375(3):268-72. DOI: 10.1016/0014-5793(95)01225-4. View

4.
Briguet A, Courdier-Fruh I, Foster M, Meier T, Magyar J . Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul Disord. 2004; 14(10):675-82. DOI: 10.1016/j.nmd.2004.06.008. View

5.
Irwin W, Bergamin N, Sabatelli P, Reggiani C, Megighian A, Merlini L . Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet. 2003; 35(4):367-71. DOI: 10.1038/ng1270. View